Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
The new Biolys provides higher concentration of L-lysine
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Subscribe To Our Newsletter & Stay Updated
